This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.The study is to examine the safety and immunogenicity responses after each dose of the vaccine and determine which concentration produces the optimal safety and immungenicity profile in both the single and repeat dose situations.
Showing the most recent 10 out of 515 publications